C4 Therapeutics Inc CCCC:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/03/24 EDT
6.74UNCH (UNCH)
Volume
28,420
Close
6.74quote price arrow up+0.31 (+4.82%)
Volume
910,138
52 week range
1.06 - 11.88
Loading...
  • Open6.70
  • Day High6.94
  • Day Low6.57
  • Prev Close6.43
  • 52 Week High11.88
  • 52 Week High Date03/04/24
  • 52 Week Low1.06
  • 52 Week Low Date12/06/23

Key Stats

  • Market Cap462.368M
  • Shares Out68.60M
  • 10 Day Average Volume1.17M
  • Dividend-
  • Dividend Yield-
  • Beta3.23
  • YTD % Change19.29

KEY STATS

  • Open6.70
  • Day High6.94
  • Day Low6.57
  • Prev Close6.43
  • 52 Week High11.88
  • 52 Week High Date03/04/24
  • 52 Week Low1.06
  • 52 Week Low Date12/06/23
  • Market Cap462.368M
  • Shares Out68.60M
  • 10 Day Average Volume1.17M
  • Dividend-
  • Dividend Yield-
  • Beta3.23
  • YTD % Change19.29

RATIOS/PROFITABILITY

  • EPS (TTM)-2.67
  • P/E (TTM)-2.53
  • Fwd P/E (NTM)-3.72
  • EBITDA (TTM)-137.151M
  • ROE (TTM)-49.50%
  • Revenue (TTM)20.756M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-638.34%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/06/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On C4 Therapeutics Inc

 

Profile

MORE
C4 Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It is focused on advancing targeted protein degradation science to create a new generation of small-molecule medicines that transform patients’ lives. By leveraging its proprietary Target ORiented ProtEin Degrader Optimizer (TORPEDO) platform, to design and optimize small molecule protein degraders that are active against their desired targets by harnessing the body’s natural process for destroying unwanted...
Bruce Downey
Lead Independent Director Non-Executive Chairman of the Board
Andrew Hirsch
President, Chief Executive Officer, Director
Kendra Adams
Chief Financial Officer, Treasurer
Mark Mossler
Chief Accounting Officer
Address
490 Arsenal Way, Suite 120
Watertown, MA
02472
United States

Top Peers

SYMBOLLASTCHG%CHG
TSHA
Taysha Gene Therapies Inc
2.57-0.01-0.39%
ITOS
Iteos Therapeutics Inc
11.66+0.17+1.48%
RNAC
Cartesian Therapeutics Inc
25.60+1.17+4.79%
TCRX
TScan Therapeutics Inc
8.56-0.09-1.04%
FULC
Fulcrum Therapeutics Inc
7.75+0.10+1.31%